Cochrane · systematic review · CD010973
Pharmacological interventions for recurrent abdominal pain in childhood
Martin, AE, Newlove‐Delgado, TV, Abbott, RA, et al. · Cochrane Database of Systematic Reviews · 2017 · Cochrane Library
Developmental, Psychosocial and Learning ProblemsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
4
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 3 · 75%Low 1 · 25%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Antispasmodics compared to placebo for recurrent abdominal pain
Population: school‐aged children (5 to 18 years of age) with recurrent abdominal pain
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Pain duration (mean pain duration, assessed at 4 weeks) Antispasmodics vs placebo | no estimate extracted | 1 study · 120 participants | Very low Downgraded: risk of bias |
Pain improvement (clinician judged, assessed at 2 weeks) Antispasmodics vs placebo | OR 3.33 [0.93, 12.01] | 1 study · 42 participants | Very low Downgraded: risk of bias |
Pain frequency (episodes of pain in 4 weeks, assessed after 4 weeks) Antispasmodics vs placebo | MD 11.3 [2.4, 20.1] | 1 study · 132 participants | Very low Downgraded: risk of bias |
Pain improvement (self reported response to treatment, assessed at 4 weeks) Antispasmodics vs placebo | OR 1.6 [0.7, 3.4] | 1 study · 115 participants | Low |